Nine clinical investigators and trainees at the Herbert Irving Comprehensive Cancer Center will receive awards from Conquer Cancer®, the ASCO Foundation, this year at ASCO's 2023 Annual Meeting
Dr. Izar has been selected as a recipient of the Pershing Sohn Prize in recognition of his innovative approach to finding a new therapeutic target for brain metastasis.
With grant support from the V Foundation, Dr. Cheng will pursue innovative research studying the interface of nutritional and gene regulatory networks in cancer.
Researchers at the Herbert Irving Comprehensive Cancer Center have found a promising new strategy for targeting adenoid cystic carcinoma (ACC), a rare but lethal form of cancer
To celebrate AAPI Heritage Month at the Herbert Irving Comprehensive Cancer Center (HICCC), we asked several of our members and faculty to share what AAPI Heritage Month means to them.
Tal Korem, PhD, shares how his lab is using a new decontamination method to prevent blood-borne microbial DNA samples from contamination and improve cancer diagnostic tools.
In this edition of Notes from the Lab, scientists at the Irving Institute for Cancer Dynamics showcase their mathematical framework for studying cancer cell evolution.
After being diagnosed in 2001 with chronic lymphocytic leukemia and again in 2018 with lung cancer, Mary Ann is now successfully managing her disease and returning to her calling as an actress.